Are you really serious? What do you not understand about a secondary and the effect it has on the share price of a company? Are you new to the market? Please say yes.
Yes, the secondary shares were all sold on the 14'th at $12.22.
The company, the selling stockholders and the underwriters named below have entered into an underwriting agreement with respect to the shares being offered. Subject to certain conditions, each underwriter has severally agreed to purchase the number of shares indicated in the following table. Goldman Sachs & Co. and J.P. Morgan Securities LLC are the representatives of the underwriters.
Underwriters Number of Shares
Goldman, Sachs & Co. 1,912,500
J.P. Morgan Securities LLC 1,575,000
Canaccord Genuity Inc. 562,500
William Blair & Company, L.L.C. 450,000
The underwriters are committed to take and pay for all of the shares being offered, if any are taken, other than the shares covered by the option described below unless and until this option is exercised. If the underwriters sell more shares than the total number set forth in the table above, the underwriters have an option to buy up to an additional 675,000 shares from the selling stockholders to cover such sales. They may exercise that option for 30 days. If any shares are purchased pursuant to this option, the underwriters will severally purchase shares in approximately the same proportion as set forth in the table above.
The following table shows per share and total underwriting discounts and commissions to be paid to the underwriters by the selling stockholders. Such amounts are shown assuming both no exercise and full exercise of the underwriters’ option to purchase 675,000 additional shares.
Perhaps you didn't hear about the secondary sold by venture capitalist shareholders who have been in this stock for over several years?
Listen to the conference call it is archived on the company website. They talk about market opportunities in the overseas markets. They are making inroads in China as well as Europe.
Yep. if these guys can execute on their plan then the sky is the limit. The market for their product overseas is amazingly large right now. Plus, they have just scratched surface here. Amazing how many fat folks there are in America.
I really wished there were more like you but unfortunately there is only around one million shares short. Is that all yours?
You're the only joke here. When you run out of cash shorting this company let us know. Or we will know that I guess when you quit with your idiotic posts every day.
My bet is this is one of the buyer's of the Secondary which is crazily priced at $13. So they are shorting at $17 and then they get shares at $13. Pretty good gig if you have a big account at Goldman.
There is a form 4 filed almost everyday so not sure what you have been looking at. Pay attention to all the new filings by the institutional funds. There were several new buys reported this period and they are just getting started. I would cover if she dips. Good Luck
It's all about the razor and blade business strategy. It's a good one. Staying with it.
Several things outside the scope of the company. The market is punishing all the stocks with substantial gains as funds with such large returns this year are being locked in. Stock had a good run, pulling back now so take advantage of it because it won't last much longer.
Stocks trade based on fundamentals or potential fundamentals. This company doesn't even have FDA approval yet and you want to put a $500 price tag on it? What time does fantasy island come on?